R33: Levetiracetam in Early Psychosis

Clinical trial NCT04317807 · COMPLETED

Trial details

NCT number: NCT04317807
Sponsor: NYU Langone Health
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Early Psychosis

Start date: 2020-08-27
Primary completion: 2025-04-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.